T.Man Pharmaceutical PCL Income Statement

Financials in millions THB. Fiscal year is January - December.

Millions THB. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Revenue	2,213	1,972	2,017	1,260	895.52
Other Revenue	13.35	7.81	8.05	3.43	5.26
Revenue	2,226	1,980	2,025	1,263	900.78
Revenue Growth (YoY)	12.42%	-2.20%	60.26%	40.25%	-
Cost of Revenue	1,133	1,003	923.57	861.26	572.32
Gross Profit	1,093	976.84	1,101	402.08	328.46
Selling, General & Admin	546.65	496.43	452.32	313.35	248.35
Operating Expenses	543.35	451.8	492.88	321.07	254.23
Operating Income	549.98	525.04	608.21	81.01	74.23
Interest Expense	-18.63	-14.85	-16.98	-7.18	-9.09
Pretax Income	531.36	510.19	591.23	73.83	65.15
Income Tax Expense	80.65	79.1	118.71	17.44	5.25
Earnings From Continuing Operations	450.7	431.09	472.52	56.39	59.89
Minority Interest in Earnings	-0	-0	-	-	-
Net Income	450.7	431.09	472.52	56.39	59.89
Net Income to Common	450.7	431.09	472.52	56.39	59.89
Net Income Growth	4.55%	-8.77%	737.91%	-5.84%	-
Shares Outstanding (Basic)	343	275	250	72	67
Shares Outstanding (Diluted)	343	275	250	72	67
Shares Change (YoY)	24.68%	10.31%	246.21%	8.20%	-
EPS (Basic)	1.31	1.56	1.89	0.78	0.90
EPS (Diluted)	1.31	1.56	1.89	0.78	0.90
EPS Growth	-16.14%	-17.29%	142.02%	-12.98%	-
Free Cash Flow	345.71	62.15	289.02	196.49	128.83
Free Cash Flow Per Share	1.01	0.23	1.16	2.72	1.93
Dividend Per Share	0.545	0.036	-	-	-
Dividend Growth	1415.00%	-	-	-	-
Gross Margin	49.12%	49.33%	54.38%	31.83%	36.46%
Operating Margin	24.71%	26.52%	30.04%	6.41%	8.24%
Profit Margin	20.25%	21.77%	23.34%	4.46%	6.65%
Free Cash Flow Margin	15.53%	3.14%	14.27%	15.55%	14.30%
EBITDA	645.11	611.56	678.68	148.29	143.51
EBITDA Margin	28.98%	30.89%	33.52%	11.74%	15.93%
D&A For EBITDA	95.12	86.52	70.48	67.28	69.28
EBIT	549.98	525.04	608.21	81.01	74.23
EBIT Margin	24.71%	26.52%	30.04%	6.41%	8.24%
Effective Tax Rate	15.18%	15.50%	20.08%	23.62%	8.06%
Revenue as Reported	2,226	1,980	2,025	1,263	900.78
Advertising Expenses	113	97	89	52	34

Source: S&P Capital IQ. Standard template. Financial Sources.